128 related articles for article (PubMed ID: 38840262)
1. Inactivation of KDM6A promotes the progression of colorectal cancer by enhancing the glycolysis.
Zhang D; Zhao X; Gao Y; Wang M; Xiao M; Zhu K; Niu W; Dai Y
Eur J Med Res; 2024 Jun; 29(1):310. PubMed ID: 38840262
[TBL] [Abstract][Full Text] [Related]
2. Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1α.
Wan W; Peng K; Li M; Qin L; Tong Z; Yan J; Shen B; Yu C
Oncogene; 2017 Jul; 36(27):3868-3877. PubMed ID: 28263974
[TBL] [Abstract][Full Text] [Related]
3. Combination of lysine-specific demethylase 6A (KDM6A) and mismatch repair (MMR) status is a potential prognostic factor in colorectal cancer.
Chen X; Yang Z; Feng J; Duan T; Pan T; Yan L; Jin T; Xiang Y; Zhang M; Chen P; Wang W; Zhang R; Chen B; Zhao L; Xie T; Sui X
Cancer Med; 2021 Jan; 10(1):317-324. PubMed ID: 33174323
[TBL] [Abstract][Full Text] [Related]
4. RPS7 inhibits colorectal cancer growth via decreasing HIF-1α-mediated glycolysis.
Zhang W; Tong D; Liu F; Li D; Li J; Cheng X; Wang Z
Oncotarget; 2016 Feb; 7(5):5800-14. PubMed ID: 26735579
[TBL] [Abstract][Full Text] [Related]
5. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract][Full Text] [Related]
6. KIF20A Promotes CRC Progression and the Warburg Effect through the C-Myc/HIF-1α Axis.
Wu M; Wu X; Han J
Protein Pept Lett; 2024; 31(2):107-115. PubMed ID: 38037834
[TBL] [Abstract][Full Text] [Related]
7. Homeobox A3 and KDM6A cooperate in transcriptional control of aerobic glycolysis and glioblastoma progression.
Yang R; Zhang G; Dong Z; Wang S; Li Y; Lian F; Liu X; Li H; Wei X; Cui H
Neuro Oncol; 2023 Apr; 25(4):635-647. PubMed ID: 36215227
[TBL] [Abstract][Full Text] [Related]
8. Histone demethylase JMJD2D activates HIF1 signaling pathway via multiple mechanisms to promote colorectal cancer glycolysis and progression.
Peng K; Zhuo M; Li M; Chen Q; Mo P; Yu C
Oncogene; 2020 Nov; 39(47):7076-7091. PubMed ID: 32989255
[TBL] [Abstract][Full Text] [Related]
9. Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer.
Wang J; Wang H; Liu A; Fang C; Hao J; Wang Z
Oncotarget; 2015 Aug; 6(23):19456-68. PubMed ID: 26062441
[TBL] [Abstract][Full Text] [Related]
10. The SLC34A2-ROS-HIF-1-induced up-regulation of EZH2 expression promotes proliferation and chemo-resistance to apoptosis in colorectal cancer.
Li X; Xing J; Wang H; Yu E
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30038060
[TBL] [Abstract][Full Text] [Related]
11. TNFα and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells.
Straus DS
Mol Cancer; 2013 Jul; 12():78. PubMed ID: 23866118
[TBL] [Abstract][Full Text] [Related]
12. A Diffusion-like Process Accommodates New Crypts During Clonal Expansion in Human Colonic Epithelium.
Olpe C; Khamis D; Chukanova M; Skoufou-Papoutsaki N; Kemp R; Marks K; Tatton C; Lindskog C; Nicholson A; Brunton-Sim R; Malhotra S; Ten Hoopen R; Stanley R; Winton DJ; Morrissey E
Gastroenterology; 2021 Aug; 161(2):548-559.e23. PubMed ID: 33895166
[TBL] [Abstract][Full Text] [Related]
13. Histone methyltransferase SETD1A interacts with HIF1α to enhance glycolysis and promote cancer progression in gastric cancer.
Wu J; Chai H; Xu X; Yu J; Gu Y
Mol Oncol; 2020 Jun; 14(6):1397-1409. PubMed ID: 32291851
[TBL] [Abstract][Full Text] [Related]
14. The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth.
Ban HS; Kim BK; Lee H; Kim HM; Harmalkar D; Nam M; Park SK; Lee K; Park JT; Kim I; Lee K; Hwang GS; Won M
Cell Death Dis; 2017 Jun; 8(6):e2843. PubMed ID: 28569777
[TBL] [Abstract][Full Text] [Related]
15. Stat5a promotes brown adipocyte differentiation and thermogenic program through binding and transactivating the Kdm6a promoter.
Liu W; Ji Y; Zhang B; Chu H; Yin C; Xiao Y
Cell Cycle; 2020 Apr; 19(8):895-905. PubMed ID: 32207362
[TBL] [Abstract][Full Text] [Related]
16. KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer.
Qiu H; Makarov V; Bolzenius JK; Halstead A; Parker Y; Wang A; Iyer GV; Wise H; Kim D; Thayaparan V; Lindner DJ; Haber GP; Ting AH; Ren B; Chan TA; Arora V; Solit DB; Lee BH
Cancer Res; 2023 Mar; 83(6):814-829. PubMed ID: 36638328
[TBL] [Abstract][Full Text] [Related]
17. H3K27me3 Demethylases Maintain the Transcriptional and Epigenomic Landscape of the Intestinal Epithelium.
Kolev HM; Swisa A; Manduchi E; Lan Y; Stine RR; Testa G; Kaestner KH
Cell Mol Gastroenterol Hepatol; 2023; 15(4):821-839. PubMed ID: 36503150
[TBL] [Abstract][Full Text] [Related]
18. NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer.
Jing Z; Liu Q; He X; Jia Z; Xu Z; Yang B; Liu P
J Exp Clin Cancer Res; 2022 Jun; 41(1):198. PubMed ID: 35689245
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus increases the anti-cancer effect of Huai Er by regulating hypoxia inducible factor-1α-mediated glycolysis in hepatocellular carcinoma.
Zhou L; Zhao Y; Pan LC; Wang J; Shi XJ; Du GS; He Q
World J Gastroenterol; 2022 Aug; 28(32):4600-4619. PubMed ID: 36157928
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor-1alpha modulates the down-regulation of the homeodomain protein CDX2 in colorectal cancer.
Zheng J; Sun X; Wang W; Lu S
Oncol Rep; 2010 Jul; 24(1):97-104. PubMed ID: 20514449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
